Faculty profile

Anne-Marie Carreau

ResearcherMédecineUniversité Laval

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université Laval directory, so their courses may be missing. Find their university profile.

Anne-Marie Carreau

Researcher

Médecine

Health Sciences

Université Laval

Quebec City, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
11 publications in the last five years, latest in 2026.
Senior (last) author on 4 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2021.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Diabetes Fatty Liver Disease Glucose Metabolism Insulin Clearance Insulin Resistance Insulin Secretion Lipid Metabolism Mitochondrial Function

Latest papers

Metabolomic and lipidomic plasma profiles according to metabolic dysfunction-associated steatotic liver diseases (MASLD) stages in the absence of type 2 diabetes (T2D).
Metabolomics : Official journal of the Metabolomic Society · 2026 · senior author
Plasma and fecal bile acids profiles in metabolic dysfunction-associated steatotic liver disease with advanced fibrosis.
American journal of physiology. Endocrinology and metabolism · 2025 · senior author
A review of multidisciplinary care in metabolic dysfunction‐associated steatohepatitis and cardiometabolic disease, with a focus on Canada
Diabetes, Obesity and Metabolism · 2025

All 18 publications

Latest funding

Early cholesterol blockade in advanced pancreatic cancer
CIHR · 2025 · Co-investigator
$719,100
Stimulating adipose tissue fatty acid disposal with low-dose, postprandial, intermittent niacin for the treatment of metabolic dysfunction-associated steatotic liver disease
CIHR · 2024 · Co-investigator
$1,197,226
Covid-19 effects on ARTErial StIffness and vascular AgiNg (CARTESIAN) study- Canada
CIHR · 2021 · Co-investigator
$347,260

All 4 grants and awards

18 publications.

Metabolomic and lipidomic plasma profiles according to metabolic dysfunction-associated steatotic liver diseases (MASLD) stages in the absence of type 2 diabetes (T2D).

Pradeau M, Coll JC, Berteaux A, Paquet V, Robillard Frayne I, Ferland S, Ruiz M, Carreau AM

Metabolomics : Official journal of the Metabolomic Society2026Senior author

DOI: 10.1007/s11306-026-02437-1 PMID: 42096005

Plasma and fecal bile acids profiles in metabolic dysfunction-associated steatotic liver disease with advanced fibrosis.

Pradeau M, Beaulieu S, Paquet V, Trottier J, Verreault M, Ferland S, Barbier O, Carreau AM

American journal of physiology. Endocrinology and metabolism2025Senior author

DOI: 10.1152/ajpendo.00346.2024 PMID: 40987517

A review of multidisciplinary care in metabolic dysfunction‐associated steatohepatitis and cardiometabolic disease, with a focus on Canada

Kim J, Raggi P, Carreau A, Wharton S, Cheng AYY, Swain MG

Diabetes, Obesity and Metabolism20253 citations

DOI: 10.1111/dom.70117

Substituting Refined Sugars With Maple Syrup Decreases Key Cardiometabolic Risk Factors in Individuals With Mild Metabolic Alterations: A Randomized, Double-Blind, Controlled Crossover Trial.

Morissette A, Agrinier AL, Gignac T, Ramadan L, Diop K, Marois J, Varin TV, Pilon G, Simard S, Larose É, Gagnon C, Arsenault BJ, Després JP, Carreau AM, Vohl MC, Marette A

The Journal of nutrition2024

DOI: 10.1016/j.tjnut.2024.08.014 PMID: 39163971

Camu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals: A randomized crossover trial.

Agrinier AL, Morissette A, Daoust L, Gignac T, Marois J, Varin TV, Pilon G, Larose É, Gagnon C, Desjardins Y, Anhê FF, Carreau AM, Vohl MC, Marette A

Cell reports. Medicine2024

DOI: 10.1016/j.xcrm.2024.101682 PMID: 39168095

Metabolic-associated fatty liver disease is characterized by a post-oral glucose load hyperinsulinemia in individuals with mild metabolic alterations.

Gignac T, Trépanier G, Pradeau M, Morissette A, Agrinier AL, Larose É, Marois J, Pilon G, Gagnon C, Vohl MC, Marette A, Carreau AM

American journal of physiology. Endocrinology and metabolism2024Senior author

DOI: 10.1152/ajpendo.00294.2023 PMID: 38477665

Glycated Hemoglobin Is Suboptimal for the Screening of Prediabetes and Type 2 Diabetes in Adults With Nonalcoholic Fatty Liver Disease.

Gignac T, Trépanier G, Paquet V, Ferland S, Carreau AM

Canadian journal of diabetes2023Senior author

DOI: 10.1016/j.jcjd.2023.06.002 PMID: 37352972

Trimester-specific gestational weight gain in women with and without previous bariatric surgeries.

Gagnon G, Carreau AM, Cloutier-Langevin C, Plante AS, John Weisnagel S, Marceau S, Biertho L, Simon Hould F, Camirand-Lemyre F, Tchernof A, Morisset AS

European journal of obstetrics, gynecology, and reproductive biology2022

DOI: 10.1016/j.ejogrb.2021.12.033 PMID: 35000759

Dietary intakes in pregnant women with previous bariatric surgery.

Gagnon G, Carreau AM, Plante AS, Savard C, Lemieux S, Weisnagel SJ, Gagnon C, Veillette J, Michaud A, Marceau S, Biertho L, Tchernof A, Morisset AS

Eating and weight disorders : EWD2022

DOI: 10.1007/s40519-021-01333-y PMID: 35060110

The Interaction of Obesity and Reproductive Function in Adolescents.

Elliott V, Waldrop SW, Wiromrat P, Carreau AM, Green MC

Seminars in reproductive medicine2022

DOI: 10.1055/s-0042-1744495 PMID: 35562099

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2021

Subject: Prospective PhD student: Diabetes Dear Professor Carreau, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Metabolomic and lipidomic plasma profiles according to metabolic dysfunction-associated steatotic liver diseases (MASLD) stages in the absence of type 2 diabetes (T2D)." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Diabetes and Healthy Liver- Unravelling the links between postprandial metabolism in type 2 diabetes and progression of metabolic fatty liver disease." (2021), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Anne-Marie Carreau

Research

Latest papers

Latest funding

Metabolomic and lipidomic plasma profiles according to metabolic dysfunction-associated steatotic liver diseases (MASLD) stages in the absence of type 2 diabetes (T2D).

Plasma and fecal bile acids profiles in metabolic dysfunction-associated steatotic liver disease with advanced fibrosis.

A review of multidisciplinary care in metabolic dysfunction‐associated steatohepatitis and cardiometabolic disease, with a focus on Canada

Substituting Refined Sugars With Maple Syrup Decreases Key Cardiometabolic Risk Factors in Individuals With Mild Metabolic Alterations: A Randomized, Double-Blind, Controlled Crossover Trial.

Camu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals: A randomized crossover trial.

Metabolic-associated fatty liver disease is characterized by a post-oral glucose load hyperinsulinemia in individuals with mild metabolic alterations.

Glycated Hemoglobin Is Suboptimal for the Screening of Prediabetes and Type 2 Diabetes in Adults With Nonalcoholic Fatty Liver Disease.

Trimester-specific gestational weight gain in women with and without previous bariatric surgeries.

Dietary intakes in pregnant women with previous bariatric surgery.

The Interaction of Obesity and Reproductive Function in Adolescents.

Early cholesterol blockade in advanced pancreatic cancer

Stimulating adipose tissue fatty acid disposal with low-dose, postprandial, intermittent niacin for the treatment of metabolic dysfunction-associated steatotic liver disease

Covid-19 effects on ARTErial StIffness and vascular AgiNg (CARTESIAN) study- Canada

Diabetes and Healthy Liver- Unravelling the links between postprandial metabolism in type 2 diabetes and progression of metabolic fatty liver disease.

Frequent collaborators

Claudia Gagnon

Anne-Sophie Morisset

Marie-Claude Vohl

Olivier Barbier

Simone Lemieux

Laurent Biertho

Julie Robitaille

Patricia Lemieux

Denis Richard

Mathieu Ferron

Sean Wharton

Fabrice Mac-Way

Matthieu Ruiz